Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: a registry-based cohort study of 164 patients.

被引:7
|
作者
Fredeau, Lisa [1 ]
Courvoisier, Delphine S. [2 ]
Mehdi, Raphael Ait [3 ]
Ingen-Housz-Oro, Saskia [4 ]
Mahe, Emmanuel [5 ]
Costedoat-Chalumeau, Nathalie [6 ]
Arnaud, Laurent [7 ]
Frances, Camille [1 ]
Mathian, Alexis [8 ]
Jachiet, Marie [9 ]
Amoura, Zahir [9 ]
Bouaziz, Jean David [9 ]
Chasset, Francois [9 ]
机构
[1] Sorbonne Univ, Hop Tenon, AP HP, Serv Dermatol & Allergol,Fac Med, Paris, France
[2] Hop Univ Geneve, Serv Epidemiol Clin, Geneva, Switzerland
[3] Grand Hop Est Francilien, Serv Dermatol, Jossigny, France
[4] Univ Paris Est Creteil EpidermE, Hop Mondor, AP HP, Serv Dermatol, Creteil, France
[5] Ctr Hosp Victor Dupuy, Serv Dermatol, Argenteuil, France
[6] Univ Paris, Hop Cochin, AP HP, Serv Med Interne,Fac Med, Paris, France
[7] Univ Strasbourg, Hop Univ Strasbourg, Ctr Natl References Malad Syst & Autoimmunes Rare, Serv Rhumatol, Strasbourg, France
[8] Sorbonne Univ, Grp Hosp Pitie Salpetriere, AP HP, Ctr Natl Reference lupus Syst Syndrome Antiphos P, Paris, France
[9] Univ Paris, Hop St Louis, AH HP, Serv Dermatol,Fac Med, Paris, France
关键词
cutaneous lupus erythematosus; evolution; predictive score; progression; risk factors; severe systemic lupus erythematosus; CLASSIFICATION; FEATURES;
D O I
10.1016/j.jaad.2022.09.028
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: No study has assessed the risk factors of progression from discoid lupus erythematosus (DLE) to severe systemic lupus erythematosus (sSLE) (defined as requiring hospitalization and specific treatment).Objective: To identify the risks factors of and generate a predicting score for progression to sSLE among patients with isolated DLE or associated with systemic lupus erythematosus with mild biological abnormalities.Methods: In this registry-based cohort study, multivariable analysis was performed using risk factors identified from literature and pruned by backward selection to identify relevant variables. The number of points was weighted proportionally to the odds ratio (OR).Results: We included 30 patients with DLE who developed sSLE and 134 patients who did not. In multivariable analysis, among 12 selected variables, an age of <25 years at the time of DLE diagnosis (OR, 2.8; 95% CI, 1.1-7.0; 1 point), phototype V to VI (OR, 2.7; 95% CI, 1.1-7.0; 1 point), and antinuclear antibody titers of >= 1:320 (OR, 15; 95% CI, 3.3-67.3; 5 points) were selected to generate the score. Among the 54 patients with a score of 0 at baseline, none progressed to sSLE, whereas a score of >= 6 was associated with a risk of approximately 40%.Limitations: Retrospective design.Conclusion: In our cohort, an age of <25 years at the time of DLE diagnosis, phototype V to VI, and antinuclear antibody titers of >= 1:320 were risk factors for developing sSLE. ( J Am Acad Dermatol 2023;88:551-9.)
引用
收藏
页码:551 / 559
页数:9
相关论文
共 50 条
  • [21] Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
    Abdelbaky, Mohammed Salah Eldin
    El Mamoun, Tarek Ahmad
    Mabrouk, Fatma Ibrahim
    Hassan, Rasha Mohamad
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2021, 33 (01)
  • [22] Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea
    Han, Jung-Yong
    Kim, Hyoungyoung
    Jung, Sun-Young
    Jang, Eun Jin
    Cho, Soo-Kyung
    Sung, Yoon-Kyoung
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [23] Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A case-control study
    Gimeno-Torres, Laura
    Carrion-Barbera, Irene
    Duran, Xavier
    Villegas, Eduardo
    Monfort, Jordi
    Carlos Salman-Monte, Tarek
    LUPUS, 2021, 30 (13) : 2095 - 2101
  • [24] Increased cardiovascular risk in Korean patients with systemic lupus erythematosus: a population-based cohort study
    Han, Jung-Yong
    Cho, Soo-Kyung
    Kim, Hyoungyoung
    Jeon, Yena
    Kang, Gaeun
    Jung, Sun-Young
    Jang, Eun Jin
    Sung, Yoon-Kyoung
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [25] Causes and Factors Associated with Frequent Hospitalization in Chinese Patients with Systemic Lupus Erythematosus: An Ambispective Cohort Study
    Liang, Han
    Pan, Hai-Feng
    Tao, Jin-Hui
    Ye, Dong-Qing
    MEDICAL SCIENCE MONITOR, 2019, 25 : 8061 - 8068
  • [26] Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)
    Galindo-Izquierdo, Maria
    Rodriguez-Almaraz, Esther
    Pego-Reigosa, Jose M.
    Lopez-Longo, Francisco J.
    Calvo-Alen, Jaime
    Olive, Alejandro
    Fernandez-Nebro, Antonio
    Martinez-Taboada, Victor
    Vela-Casasempere, Paloma
    Freire, Mercedes
    Narvaez, Francisco J.
    Rosas, Jose
    Ibanez-Barcelo, Monica
    Uriarte, Esther
    Tomero, Eva
    Zea, Antonio
    Horcada, Loreto
    Torrente, Vicenc
    Castellvi, Ivan
    Calvet, Joan
    Menor-Almagro, Raul
    Aguirre Zamorano, Maria A.
    Raya, Enrique
    Diez-Alvarez, Elvira
    Vazquez-Rodriguez, Tomas
    Garcia de la Pena, Paloma
    Movasat, Atusa
    Andreu, Jose L.
    Richi, Patricia
    Marras, Carlos
    Montilla-Morales, Carlos
    Hernandez-Cruz, Blanca
    Marenco de la Fuente, Jose L.
    Gantes, Maria
    Ucar, Eduardo
    Alegre-Sancho, Juan J.
    Manero, Javier
    Ibanez-Ruan, Jesus
    Rodriguez-Gomez, Manuel
    Quevedo, Victor
    Hernandez-Beriain, Jose
    Silva-Fernandez, Lucia
    Alonso, Fernando
    Perez, Sabina
    Rua-Figueroa, Inigo
    MEDICINE, 2016, 95 (09)
  • [27] Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study
    Westermann, Rasmus
    Zobbe, Kristian
    Cordtz, Rene
    Haugaard, Jeanette H.
    Dreyer, Lene
    LUPUS, 2021, 30 (05) : 752 - 761
  • [28] Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus
    Torrente-Segarra, V.
    Salman-Monte, T. C.
    Rua-Figueroa, I.
    Perez-Vicente, S.
    Lopez-Longo, F. J.
    Galindo-Izquierdo, M.
    Calvo-Alen, J.
    Olive-Marques, A.
    Ibanez-Ruan, J.
    Horcadam, L.
    Sanchez-Atrio, A.
    Montilla, C.
    Rodriguez-Gomez, M.
    Diez-Alvarez, E.
    Martinez-Taboada, V.
    Andreu, J. L.
    Fernandez-Berrizbeitia, O.
    Hernandez-Beriain, J. A.
    Gantes, M.
    Hernandez-Cruz, B.
    Pecondon-Espanol, A.
    Marras, C.
    Bonilla, G.
    Pego-Reigosa, J. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : S40 - S47
  • [29] Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort
    Ugarte-Gil, M. F.
    Wojdyla, D.
    Pastor-Asurza, C. A.
    Gamboa-Cardenas, R. V.
    Acevedo-Vasquez, E. M.
    Catoggio, L. J.
    Garcia, M. A.
    Bonfa, E.
    Sato, E. I.
    Massardo, L.
    Pascual-Ramos, V.
    Barile, L. A.
    Reyes-Llerena, G.
    Iglesias-Gamarra, A.
    Molina-Restrepo, J. F.
    Chacon-Diaz, R.
    Alarcon, G. S.
    Pons-Estel, B. A.
    LUPUS, 2018, 27 (04) : 536 - 544
  • [30] Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus
    Joyce, Daniel P.
    Berger, Jeffrey S.
    Guttmann, Allison
    Hasan, Ghadeer
    Buyon, Jill P.
    Belmont, H. Michael
    Salmon, Jane
    Askanase, Anca
    Bathon, Joan
    Geraldino-Pardilla, Laura
    Ali, Yousaf
    Ginzler, Ellen M.
    Putterman, Chaim
    Gordon, Caroline
    Helmick, Charles G.
    Barbour, Kamil E.
    Gold, Heather T.
    Parton, Hilary
    Izmirly, Peter M.
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)